Patents-Review.com
ClassID:

109618 ⎘

C12N2710/10033 - CPC Classification

Classification description:

dsDNA viruses; Details; Adenoviridae Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory

Recent Application in this class:
#1
20250027056
2025-01-23

Adeno-Associated-Virus Rep Sequences, Vectors and Viruses

 #2
20240083953
2024-03-14

Desmoglein 2 (DSG2) Binding Proteins and Uses Therefor

 #3
20230127169
2023-04-27

STRUCTURE OF ONCOLYTIC VIRUS COMPRISING BISPECIFIC NUCLEIC ACID MOLECULE

 #4
20220325302
2022-10-13

ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR RESTORING PAH GENE FUNCTION AND METHODS OF USE THEREOF

 #5
20220127308
2022-04-28

Desmoglein 2 (DSG2) binding proteins and uses therefor

 #6
20210340569
2021-11-04

NOVEL AAV8 MUTANT CAPSIDS AND COMPOSITIONS CONTAINING SAME

 #7
20210177921
2021-06-17

TARGETING MOIETY-DECORATED ONCOLYTIC VIRUSES

 #8
20210130794
2021-05-06

Adeno-associated virus compositions for restoring PAH gene function and methods of use thereof

 #9
20200330533
2020-10-22

Biomarkers and combination therapies using oncolytic virus and immunomodulation

 #10
20200277336
2020-09-03

Desmoglein 2 (DSG2) binding proteins and uses therefor

 #11
20190375797
2019-12-12

Methods and therapeutics comprising ligand-targeted ELPs

 #12
20190292525
2019-09-26

Adeno-associated-virus Rep sequences, vectors and viruses

 #13
20190269711
2019-09-05

Methods of treating cancer

 #14
20190092819
2019-03-28

Desmoglein 2 (DSG2) binding proteins and uses therefor

 #15
20190078119
2019-03-14

AAV8 mutant capsids and compositions containing same

 #16
20180243430
2018-08-30

Composition for intracellular delivery containing adenovirus protein VI-derived peptide and anticancer pharmaceutical composition containing same

 #17
20180169271
2018-06-21

ARMED REPLICATION-COMPETENT ONCOLYTIC ADENOVIRUSES

 #18
20180099014
2018-04-12

Engineered oncolytic viruses containing hyper-binding sites to sequester and suppress activity of oncogenic transcription factors as a novel treatment for human cancer

 #19
20180072809
2018-03-15

Oncolytic adenoviruses coding for bi-specific antibodies

 #20
20170258906
2017-09-14

Virus-PCION complex having enhanced antitumor effect by using electromagnetic field

 #21
20170247419
2017-08-31

Desmoglein 2 (DSG2) binding proteins and uses therefor

 #22
20170202892
2017-07-20

Conditionally replicating adenovirus to express REIC gene

 #23
20170080106
2017-03-23

Decorin gene delivery system and cancer treatment

 #24
20160312207
2016-10-27

R-SPONDIN ANTAGONISTS AND METHODS OF TREATING CANCER ASSOCIATED WITH ABERRANT ACTIVATION OF WNT SIGNALING

 #25
20160017004
2016-01-21

METHODS AND THERAPEUTICS COMPRISING LIGAND-TARGETED ELPs

 #26
20160002607
2016-01-07

Adeno-associated-virus Rep sequences, vectors and viruses

 #27
20150246949
2015-09-03

Desmoglein 2 (DSG2) Binding Proteins and Uses Therefor

 #28
20150098925
2015-04-09

COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASES USING DISEASE-SPECIFIC PROMOTER

 #29
20140377221
2014-12-25

Biomarkers and combination therapies using oncolytic virus and immunomodulation

 #30
20080132449
2008-06-05

Decorin gene delivery system and cancer treatment